Veterinary Molecular Diagnostics Market
Veterinary Molecular Diagnostics Market Growth Forecast 2024-2034
The global veterinary molecular diagnostics market is poised for significant growth, projected to expand at a CAGR of 7.84%, with market valuation increasing from USD 195.47 million in 2024 to USD 378.22 million by 2034. This growth is driven by rising pet ownership, advancements in diagnostic technologies, and increasing awareness about animal health.
Key Market Trends
- Growing Pet Adoption: Over 61% of households in the U.S. owned a pet in 2023, driving demand for advanced diagnostics.
- Technological Advancements: Innovations in PCR and next-generation sequencing (NGS) are enabling faster and more accurate diagnostics.
- Increased Livestock Health Expenditure: Rising global demand for animal-derived products is boosting the need for molecular diagnostics in livestock management.
Market Segmentation
By Product Type:
- PCR Kits (Dominant with 51% market share in 2024)
- RT-PCR Kits
- DNA Sequencing Kits
- Microarray Kits
By Species Type:
- Livestock Animals
- Cattle
- Poultry
- Aquatic Animals
- Companion Animals
- Canine
- Feline
- Avian
By Disease Type:
- Influenza
- Porcine Reproductive and Respiratory Syndrome (PRRS)
- Newcastle Disease
- Others
By End User:
- Veterinary Hospitals
- Research Institutes
- Clinical Laboratories
Regional Insights
- North America: Dominates with a 34.6% market share due to high pet adoption rates and advanced veterinary healthcare infrastructure.
- Asia Pacific: Fastest-growing region with a CAGR of 10.3%, led by India and China due to their robust livestock industries.
- Europe: Home to high-quality diagnostic procedures, contributing significantly to the market share.
Challenges
- High Costs: Advanced diagnostic procedures and equipment remain expensive, limiting accessibility.
- Lack of Skilled Professionals: Shortages in trained personnel pose challenges to market growth.
Competitive Landscape
Major players in the veterinary molecular diagnostics market include:
- IDEXX Laboratories
- Thermo Fisher Scientific
- Zoetis
- Neogen Corporation
Recent Developments:
- In 2024, IDEXX launched advanced PCR diagnostic kits, enhancing test accuracy and speed.
- Neogen Corporation introduced DNA screening tools for genetic disease detection in pets.
FAQs
1. What is the growth outlook for the veterinary molecular diagnostics market?
The market is expected to grow at a CAGR of 7.84% during 2024-2034.
2. Which region is expected to dominate the market?
North America leads with a significant share, while Asia Pacific shows the fastest growth.
3. What are the leading product segments?
PCR kits dominate, accounting for 51% of the market share in 2024.
Table: Veterinary Molecular Diagnostics Market at a Glance
| Parameter |
Value (2024) |
Value (2034) |
|---|---|---|
|
Market Size |
US$ 195.47 million |
US$ 378.22 million |
|
CAGR |
7.84% |
– |
|
Leading Product Segment |
PCR Kits (51%) |
– |
|
Dominant Region |
North America (34.6%) |
– |
Take Action Now!
Contact us today to access the full report and propel your business forward.

